These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7518732)

  • 1. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
    Hwang SJ; Lee SD; Wu JC; Chang CF; Lu CL; Tsay SH; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):262-9. PubMed ID: 7518732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
    Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythrocytosis associated with hepatocellular carcinoma. Two case reports].
    Argumanis E; Quispe D; Ruiz E
    Rev Gastroenterol Peru; 2002; 22(1):84-7. PubMed ID: 11961573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
    Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T
    Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytosis caused by an erythropoietin-producing hepatocellular carcinoma.
    Matsuyama M; Yamazaki O; Horii K; Higaki I; Kawai S; Mikami S; Higashino M; Oka H; Nakai T; Inoue T
    J Surg Oncol; 2000 Nov; 75(3):197-202. PubMed ID: 11088052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum erythropoietin measurements by a one-step sandwich enzyme linked immunosorbent assay in patients with hepatocellular carcinoma and liver cirrhosis.
    Sawabe Y; Iida S; Tabata Y; Yonemitsu H
    Jpn J Clin Oncol; 1993 Oct; 23(5):273-7. PubMed ID: 7693989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
    Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
    Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.
    Giannini EG; Sammito G; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Trevisani F;
    Cancer; 2014 Jul; 120(14):2150-7. PubMed ID: 24723129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
    Hwang SJ; Luo JC; Li CP; Chu CW; Wu JC; Lai CR; Chiang JH; Chau GY; Lui WY; Lee CC; Chang FY; Lee SD
    World J Gastroenterol; 2004 Sep; 10(17):2472-7. PubMed ID: 15300887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.
    Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Chang FY; Lee SD; Lui WY; Chiang JH
    J Gastroenterol Hepatol; 1999 Aug; 14(8):807-10. PubMed ID: 10482434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum erythropoietin concentrations in patients with hepatocellular carcinoma.
    Kew MC; Fisher JW
    Cancer; 1986 Dec; 58(11):2485-8. PubMed ID: 2429757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ferritin in hepatocellular carcinoma.
    Zhou XD; Stahlhut MW; Hann HL; London WT
    Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythrocytosis in patients with hepatocarcinoma in alcoholic cirrhosis: ectopic production of erythropoietin?].
    Giovanardi P; Sacchetti C; Cameroni P; Grandi M
    Recenti Prog Med; 1998 May; 89(5):250-2. PubMed ID: 9676132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
    Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
    Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
    Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].
    Jia HL; Xing XJ; Ye QH; Qin LX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.
    Ülger Y; Delik A
    Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):769-773. PubMed ID: 34974464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
    Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.